Universitätsklinikum Heidelberg

Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis A Multicenter Cohort Study (2025) Bohn A, Angstwurm K, Bien CG, Doppler K, Ehmke L, Havla J, Hoffmann F, et al. Journal article Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article Pharmazeutisches Entlassmanagement für Krankenhausapotheker*innen (2025) Richling I, Berger S, Britz H, Brünn R, Griese-Mammen N, Kirschke S, Kriegisch-Stumpf A, et al. Journal article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article Deep learning-based contour propagation in magnetic resonance imaging-guided radiotherapy of lung cancer patients (2025) Wei C, Eze C, Klaar R, Thorwarth D, Warda C, Taugner J, Hörner-Rieber J, et al. Journal article Digital empowerment on hold: DiGA adoption gaps−a German national cross-sectional patient survey study (2025) Kremer P, Fink D, Morf H, Labinsky H, Gente K, Aries P, Krusche M, et al. Journal article Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group (2025) De Cock L, Palubeckaitė I, Bersani F, Faehling T, Pasquali S, Umbaugh S, Meister MT, et al. Journal article, Review article The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study (2025) Schneeweiss A, Fasching P, Thill M, van Mackelenbergh M, Marme F, Tesch H, Fehm TN, et al. Journal article Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland (2025) Seidel D, Pana ZD, Ebrahimi-Fakhari D, Butzer SK, Mehler K, Reinhold I, Simon A, et al. Journal article Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma (2025) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article